Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Observational
Started
2025-07
Last updated
2025-07-11
Condition(s) studied
Lung Cancer (Diagnosis)
Study summary
CT imaging data from lung cancer (NSCLC and SCLC) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Patients were treated for lung cancer in Wuhan Union Hospital from July 2025 to July 2026;
2. Aged \> 18 years old;
3. At least one CT scan before treatment;
4. Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
Exclusion criteria:
1. Poor image quality;
2. Incomplete clinical data or loss of follow-up;
3. Presence of another primary malignancy other than lung cancer;
4. Unclear pathological diagnosis.
Primary outcome measure(s)
Progression-free survival — 1 year
disease-free survival — 1 year
overall survival — 1 year
Trial sites (1)
Facility
City
Region
Status
Union Hospital，Tongji Medical College，Huazhong University of Science and Technology
Wuhan
Hubei
Recruiting
More Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.